{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:15:33Z","timestamp":1793812533102,"version":"4.6.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Adv Skin Wound Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>Radiation-induced skin injuries such as lesions (RSLs) and dermatitis are the most common complication during radiotherapy (RT) for nasopharyngeal carcinoma, but little is known about risk factors unique to oncology. This study sought a greater understanding of these risk factors to stratify patients based on risk and guide clinical decision-making.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>Investigators analyzed the data of 864 consecutive patients referred to the RT center of the Southern Theater General Hospital for a new RSL from 2013 to 2019. These patients were followed up for an average of approximately 16 months until their death or March 30, 2020, whichever came first. Multivariate logistic regression analysis and Cox proportional hazards model were used to identify predictors of grade 3 or 4 dermatitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>The main causes of treatment interruption included dermatitis and oral mucositis. Significant patient-specific risk factors for RSLs included current smoking, current drinking, and lower Karnofsky Performance Scale score and significant procedure-specific risk factors included receiving intensity-modulated radiation therapy (IMRT), hyperfractionated RT, induction chemotherapy, multicycle chemotherapy, and taxol- and cisplatin-based drugs. The three factors that independently predicted risk of RSL were IMRT, lower Karnofsky Performance Scale score, and multicycle chemotherapy. Comparing predictive factors among patients with severe RSL revealed that patients who received IMRT were more likely to develop grade 3 or 4 dermatitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS<\/jats:title>\n            <jats:p>Oncology providers should note that IMRT is an aggressive technique with a trend toward increased RSL. Providers should pay special attention to adverse effects to skin in patients with nasopharyngeal carcinoma.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/01.asw.0000797952.41753.f4","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T17:04:16Z","timestamp":1637600656000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Morbidity in Patients with Nasopharyngeal Carcinoma and Radiation-Induced Skin Lesions: Cause, Risk Factors, and Dermatitis Evolution and Severity"],"prefix":"10.1097","volume":"34","author":[{"given":"Zexin","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"51","key":"bib1-20250615","doi-asserted-by":"crossref","first-page":"e18484","DOI":"10.1097\/MD.0000000000018484","article-title":"Survival without concurrent chemotherapy for locoregionally advanced nasopharyngeal carcinoma treated with induction chemotherapy plus intensity-modulated radiotherapy: single-center experience from an endemic area","volume":"98","year":"2019","journal-title":"Medicine"},{"issue":"4","key":"bib2-20250615","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/0284186X.2018.1543948","article-title":"Efficacy and toxicity of proton with photon radiation for locally advanced nasopharyngeal carcinoma","volume":"58","year":"2019","journal-title":"Acta Oncol"},{"key":"bib3-20250615","first-page":"Jco2003237","article-title":"Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO guideline","year":"2021","journal-title":"J Clin Oncol"},{"issue":"51","key":"bib4-20250615","doi-asserted-by":"crossref","first-page":"e23523","DOI":"10.1097\/MD.0000000000023523","article-title":"Efficacy of different plant extracts in the prevention of radiation dermatitis in radiotherapy patients with nasopharyngeal carcinoma: a protocol for a Bayesian network meta-analysis","volume":"99","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"bib5-20250615","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpainsymman.2019.03.017","article-title":"The impact of radiodermatitis on breast cancer patients\u2019 quality of life during radiotherapy: a prospective cohort study","volume":"58","year":"2019","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"bib6-20250615","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijrobp.2018.08.024","article-title":"Hypofractionated whole-breast irradiation in large-breasted women\u2014is there a dosimetric predictor for acute skin toxicities?","volume":"103","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"bib7-20250615","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ijrobp.2018.05.060","article-title":"Long-term late toxicity, quality of life, and emotional distress in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy","volume":"102","year":"2018","journal-title":"Int J Radiat Oncol Biol Physics"},{"issue":"2","key":"bib8-20250615","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijrobp.2018.02.006","article-title":"A randomized trial of mometasone furoate 0.1% to reduce high-grade acute radiation dermatitis in breast cancer patients receiving postmastectomy radiation","volume":"101","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"44","key":"bib9-20250615","doi-asserted-by":"crossref","first-page":"e8202","DOI":"10.1097\/MD.0000000000008202","article-title":"Association between XRCC1 single-nucleotide polymorphism and acute radiation reaction in patients with nasopharyngeal carcinoma: a cohort study","volume":"96","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"bib10-20250615","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00384-020-03517-x","article-title":"Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy","volume":"35","year":"2020","journal-title":"Int J Colorectal Dis"},{"issue":"25","key":"bib11-20250615","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.2013.54.6309","article-title":"Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer","volume":"32","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4","key":"bib12-20250615","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s40257-020-00519-x","article-title":"Dermatologic sequelae associated with radiation therapy","volume":"21","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"bib13-20250615","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.oraloncology.2019.05.013","article-title":"Oral mucositis in head and neck cancer: evidence-based management and review of clinical trial data","volume":"95","year":"2019","journal-title":"Oral Oncol"},{"issue":"Suppl 1","key":"bib14-20250615","first-page":"E905","article-title":"Toxicity of concomitant cetuximab and radiotherapy with or without initial taxane-based induction chemotherapy in locally advanced head and neck cancer","volume":"38","year":"2016","journal-title":"Head Neck"},{"issue":"6","key":"bib15-20250615","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1002\/cam4.2179","article-title":"Necessity of concurrent chemotherapy in N2-3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of >\/=3 cycles followed by intensity-modulated radiotherapy","volume":"8","year":"2019","journal-title":"Cancer Med"},{"issue":"2","key":"bib16-20250615","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/hed.25997","article-title":"Analysis of skin dose distribution for the prediction of severe radiation dermatitis in head and neck squamous cell carcinoma patients treated with concurrent chemo-radiotherapy","volume":"42","year":"2020","journal-title":"Head & Neck"},{"key":"bib17-20250615","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.2147\/OTT.S172018","article-title":"Altered fractionation radiotherapy with or without chemotherapy in the treatment of head and neck cancer: a network meta-analysis","volume":"11","year":"2018","journal-title":"OncoTargets Ther"},{"issue":"2","key":"bib18-20250615","first-page":"71","article-title":"Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: part I. Conventional chemotherapeutic drugs","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"bib19-20250615","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/14737140.2018.1489245","article-title":"Hypofractionated radiation treatment in the management of breast cancer","volume":"18","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"issue":"4","key":"bib20-20250615","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00066-019-01534-6","article-title":"Improved treatment outcome and lower skin toxicity with intensity-modulated radiotherapy vs. 3D conventional radiotherapy in anal cancer","volume":"196","year":"2020","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"bib21-20250615","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.18632\/oncotarget.13830","article-title":"Dosimetric evaluation of the skin-sparing effects of 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for left breast cancer","volume":"8","year":"2017","journal-title":"Oncotarget"},{"issue":"18","key":"bib22-20250615","doi-asserted-by":"crossref","first-page":"e0502","DOI":"10.1097\/MD.0000000000010502","article-title":"Radiotherapy alone and with concurrent chemotherapy for nasopharyngeal carcinoma: a retrospective study","volume":"97","year":"2018","journal-title":"Medicine"},{"issue":"3","key":"bib23-20250615","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1016\/j.ijrobp.2011.06.1950","article-title":"Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique","volume":"82","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 1","key":"bib24-20250615","first-page":"E1481","article-title":"Prospective randomized controlled trial to compare 3-dimensional conformal radiotherapy to intensity-modulated radiotherapy in head and neck squamous cell carcinoma: long-term results","volume":"38","year":"2016","journal-title":"Head Neck"},{"issue":"3","key":"bib25-20250615","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/annonc\/mdx770","article-title":"A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02)","volume":"29","year":"2018","journal-title":"Ann Oncol"},{"issue":"5","key":"bib26-20250615","doi-asserted-by":"crossref","first-page":"551","DOI":"10.5732\/cjc.009.10518","article-title":"Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma","volume":"29","year":"2010","journal-title":"Chinese J Cancer"},{"issue":"10","key":"bib27-20250615","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s12094-012-0864-5","article-title":"Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma","volume":"14","year":"2012","journal-title":"Clin Transl Oncol"},{"issue":"6","key":"bib28-20250615","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00280-017-3297-6","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study","volume":"79","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"bib29-20250615","first-page":"6826","article-title":"LncRNA HOXA11-AS accumulation-induced microRNA-761 downregulation regulates cell growth by targeting TRIM29 in papillary thyroid cancer","volume":"11","year":"2019","journal-title":"Am J Transl Res"},{"issue":"12","key":"bib30-20250615","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1002\/hed.24909","article-title":"Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: comparison of failure pattern and toxicities between intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy","volume":"39","year":"2017","journal-title":"Head Neck"},{"issue":"1","key":"bib31-20250615","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13014-019-1294-0","article-title":"Efficacy and safety of intensity-modulated radiation therapy versus three-dimensional conformal radiation treatment for patients with gastric cancer: a systematic review and meta-analysis","volume":"14","year":"2019","journal-title":"Radiat Oncol (London, England)"},{"issue":"2","key":"bib32-20250615","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s13193-019-01024-2","article-title":"Tolerance of radical radiotherapy among elderly head and neck cancer patients","volume":"11","year":"2020","journal-title":"Indian J Surg Oncol"},{"issue":"5","key":"bib33-20250615","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00066-014-0609-1","article-title":"Radiation recall dermatitis after docetaxel chemotherapy. Treatment by antioxidant ointment","volume":"190","year":"2014","journal-title":"Strahlenther Onkol"},{"issue":"42","key":"bib34-20250615","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.1016\/j.chroma.2009.08.076","article-title":"Development and validation of a normal-phase high-performance thin layer chromatographic method for the analysis of sulfamethoxazole and trimethoprim in co-trimoxazole tablets","volume":"1216","year":"2009","journal-title":"J Chromatogr A"}],"container-title":["Advances in Skin &amp; Wound Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.ASW.0000797952.41753.f4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T21:06:20Z","timestamp":1750021580000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.ASW.0000797952.41753.f4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/01.asw.0000797952.41753.f4","relation":{},"ISSN":["1538-8654","1527-7941"],"issn-type":[{"value":"1538-8654","type":"electronic"},{"value":"1527-7941","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}